Cancer Diagnostics, Inc. provides medical tissue marking dyes and equipment for histology and cytology applications. It is ISO 13485 Accredited and FDA cGMP Compliant.

Cancer Diagnostics, Inc.

Cancer Diagnostics  Inc | 3 followers on LinkedIn. 

Cancer Diagnostics Inc

DNSSEC

DMARC

Product Schema

Microdata for Google Shopping

AggregateRating Schema

Akamai Hosted

Oracle Cloud

IONOS Mail

1and1 DNS

CEO, Founder

Patrick O'Neill

Sales Executive

Brian Alciatore

Sales and Support

Gia Nordman

Director of Manufacturing and Product Development

Jonathan Kent

Operations Director

Mark Seidel

Operations

Allain Ngam

Territory Sales Manager

Bradshaw Hammond

Claire Sanders

Senior Territory Manager

Jennifer Portnoy Felker

Jim Culp

North Carolina Health Diagnostics Companies

East Coast Medical Device Companies

United States Medical Device Companies (Top 10K)

North Carolina Companies With More Than 10 Employees (Top 10K)

Cancer Diagnostics is a provider of anatomic pathology products. It developed the first commercially available 7-dye color system for marking tissue margins and today supplies over 6,000 customers with more than 7,000 products in over 50 countries. Cancer Diagnostics, Inc. is the longest tenured founder-led anatomic pathology products company in the United States.

Advertising, Business and Retail Services

Durham

North Carolina

United States

North America

Cancer Diagnostics

India

Asia

Malaysia

Brazil

South America

Ukraine

Europe

HTML5

Google Fonts

Google Maps API

Fonts.com

Apache Server

jQuery

Bootstrap

Google Analytics

Google Tag Manager

Adobe Fonts

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 19, 2024 2:50 PM	a2fc060e
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 19, 2024 2:50 PM	94b3eeb9
crunchbase trigger	general	Nov 19, 2024 2:50 PM	871c4789
crunchbase profile	general	Nov 20, 2024 4:49 AM	252a5181
li profile	general	Nov 19, 2024 2:50 PM	33acfa56
translate crunchbase fundingrounds	general	Nov 20, 2024 5:35 AM	8daeec02
peers	general	Nov 19, 2024 2:50 PM	31f3745a
news basic	general	Nov 19, 2024 2:50 PM	96528b28
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

CANC

COM:CANCERDIAGNOSTICS

Cancer Diagnostics, Inc.